Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. (Q34404179)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. |
scientific article |
Statements
1 reference
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. (English)
1 reference
Paul A Meyers
1 reference
Cindy L Schwartz
1 reference
Mark Krailo
1 reference
Eugenie S Kleinerman
1 reference
Donna Betcher
1 reference
Mark L Bernstein
1 reference
Ernest Conrad
1 reference
William Ferguson
1 reference
Mark Gebhardt
1 reference
Allen M Goorin
1 reference
Michael B Harris
1 reference
John Healey
1 reference
Andrew Huvos
1 reference
Michael Link
1 reference
Joseph Montebello
1 reference
Helen Nadel
1 reference
Michael Nieder
1 reference
Judith Sato
1 reference
Gene Siegal
1 reference
Michael Weiner
1 reference
Robert Wells
1 reference
Lester Wold
1 reference
Richard Womer
1 reference
Holcombe Grier
1 reference
1 reference
Identifiers
1 reference